Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Published Online: 2016-04-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alejandro Yovine•Alice T Shaw•Armando Santoro•Benjamin J Solomon•D Ross Camidge•Daniel S W Tan•Dong-Wan Kim•Enriqueta Felip•Geoffrey Liu•Gregory J Riely•Johan Vansteenkiste•Jürgen Wolf•Laura Q M Chow•Martin Schuler•Michael Thomas•Ranee Mehra•Santosh Sutradhar•Siyu Li•Sunil Sharma•Tomasz Szczudlo•Tommaso De Pas
